EMA Veterinary Medicines Info Day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 March 2024, 14:00 (CET) to 15 March 2024, 12:30 (CET)

Submitted by Anonymous (not verified) on 14 March 2024 - 10:51

EMA Veterinary Medicines Info Day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 March 2024, 14:00 (CET) to 15 March 2024, 12:30 (CET)

Human medicines European public assessment report (EPAR): Sustiva, efavirenz, Date of authorisation: 28/05/1999, Revision: 48, Status: Withdrawn

Submitted by Anonymous (not verified) on 14 March 2024 - 7:59

Human medicines European public assessment report (EPAR): Sustiva, efavirenz, Date of authorisation: 28/05/1999, Revision: 48, Status: Withdrawn

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Haematology-Hemostaseology, PIP number:

Submitted by Anonymous (not verified) on 13 March 2024 - 16:47

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Haematology-Hemostaseology, PIP number: P/0035/2022

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness